辩论:重症患者间歇性血液透析与连续性肾脏替代治疗:支持连续性肾脏替代治疗的观点
本文为支持连续性肾脏替代治疗(CKRT)的辩论稿,指出CKRT是现代重症监护中占主导地位的肾脏替代治疗模式之一,适用于血流动力学不稳定的重症患者,可精确调节溶质和液体清除,并允许早期物理治疗;随机临床试验未显示CKRT与间歇性血液透析的死亡率差异,但观察性研究提示CKRT与更好的短期和长期肾脏恢复及脱离肾脏替代治疗相关。
要点
- CKRT是血流动力学不稳定重症患者首选的肾脏替代治疗模式。
- 随机临床试验未显示CKRT与间歇性血液透析的死亡率差异。
- 观察性研究提示CKRT与更好的肾脏恢复和脱离肾脏替代治疗相关。
核心结论
- CKRT是现代重症监护中占主导地位的肾脏替代治疗模式之一,可满足重症患者最严重阶段的临床需求。
研究设计与样本
- 本文为辩论稿,支持在重症患者中使用连续性肾脏替代治疗而非间歇性血液透析。
主要发现
- CKRT适用于血流动力学不稳定的重症患者。
- 随机临床试验未显示CKRT与间歇性血液透析之间的死亡率差异。
- 观察性研究提示,与间歇性血液透析相比,CKRT与更好的短期和长期肾脏恢复及脱离肾脏替代治疗相关,但易受偏倚影响。
- 接受CKRT的患者可安全地早期进行物理治疗和康复。
临床怎么用
- 原文未据此给出推荐。
局限性
- 观察性研究证据易受偏倚影响。
- 随机临床试验未显示CKRT与间歇性血液透析的死亡率差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Continuous kidney replacement therapy (CKRT) is well entrenched as one of the dominant KRT modalities in modern critical care practice. Since its introduction four decades ago, there have been considerable innovations in CKRT machines that have improved precision, safety, and simplicity. CKRT is the preferred KRT modality for critically ill patients with hemodynamic instability. Early physical therapy and rehabilitation can be feasibly and safely provided to patients connected to CKRT, thus obviating concerns about immobility. Although randomized clinical trials have not shown a mortality difference when comparing CKRT and intermittent hemodialysis, CKRT allows precision delivery of solute and fluid removal that can be readily adjusted in the face of dynamic circumstances. Accumulated evidence from observational studies, although susceptible to bias, has shown that CKRT, when compared with intermittent hemodialysis, is associated with better short- and long-term kidney recovery and KRT independence. Critical care medicine encompasses a wide range of sick patients, and no single KRT modality is likely to ideally suit every patient in every context and for every condition. The provision of KRT represents a spectrum of modalities to which patients can flexibly transition in response to their evolving condition. As a vital tool for organ support in the intensive care unit, CKRT enables the personalization of KRT to meet the clinical demands of patients during the most severe phases of their illness.
引用
- Bagshaw SM, Neyra JA, Tolwani AJ, et al. Debate: Intermittent Hemodialysis versus Continuous Kidney Replacement Therapy in the Critically Ill Patient: The Argument for CKRT. Clin J Am Soc Nephrol. 2023. PMID: 39074305. doi:10.2215/CJN.0000000000000056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。